You need a clear picture of what’s going on. That means labeling the right markers, exclusively, time after time. Our MACS®primary-conjugated antibodies give you that level of specificity as they are pre-validated for use with our ultra high content MACSima™ Imaging Platform. We validate our antibodies for functionality on FFPE- or PFA-fixed tissues or cells of either human or mouse origin, and our reproducible and recombinant technologies fully support our automated cyclic staining protocol (MICS). Our constantly expanding portfolio means your ultra high content imaging experiments will stake out new frontiers in the understanding of biological systems.